IntegriChain Launches Comprehensive State Price Transparency Reporting System to Support Evolving Regulatory Landscape

Meeting the Moment with a Comprehensive, Market-Leading System for Evolving State Mandates

PHILADELPHIA--(BUSINESS WIRE)--IntegriChain, a leading provider of pharmaceutical revenue optimization technology and data intelligence, today announced the launch of its AI-powered State Price Transparency Reporting (SPTR) system. As state-level price transparency mandates continue to expand and evolve, IntegriChain is meeting the moment with a comprehensive, market-leading solution built on deep regulatory expertise, combined with advanced automation and real-time analytics.

Developed in close collaboration with top 20 pharmaceutical manufacturers, the new SPTR platform leverages machine learning and intelligent data pipelines to identify required reports automatically, aggregate pricing data across multiple systems, and continuously adapt to new state requirements. A unified data layer and seamless single sign-on (SSO) integration across all ICyte modules provide manufacturers with full visibility and control through a single, secure interface.

With a state price transparency reporting customer base of more than 110 pharmaceutical manufacturers, IntegriChain is recognized by state regulators as the industry’s most accurate and trusted SPTR vendor. IntegriChain’s credibility and leadership in this space were further reinforced by the appointment of industry expert Lynetta Moore to the Oregon Rulemaking Committee, underscoring the company’s direct influence in shaping public policy and regulatory frameworks.

“As state-level price transparency mandates continue to expand and evolve, IntegriChain offers a comprehensive, market-leading solution. This solution is built on extensive regulatory expertise, established relationships with state agencies, and a strong compliance record, allowing IntegriChain to effectively address current industry needs,” says Josh Halpern, CEO of IntegriChain. “This launch is a great example of how AI can simplify regulatory complexity,” added Shai Fiss, Chief AI and Technology Officer at IntegriChain. “Our platform roadmap doesn’t just automate reporting, it learns from it and is getting smarter. Our next step is to integrate NLP and anomaly detection across state submissions, transforming what used to be manual, error-prone processes into intelligent, continuously improving systems. This is how compliance becomes both smarter and faster.”

About IntegriChain
IntegriChain is the leading provider of revenue optimization technology and insights for the Pharma industry. The company’s unique combination of data management, enterprise applications, consulting, and outsourcing helps manufacturers achieve better financial results by connecting commercial execution to net revenue. IntegriChain is backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Technology. IntegriChain is headquartered in Philadelphia, PA, with offices in Ambler, PA, and Pune, India. For more information, visit www.integrichain.com or follow on LinkedIn.